International FMD vaccine consortium to gain £3.1m in funding
A new project focused on the development of a more affordable and effective foot-and-mouth disease (FMD) vaccine is being backed with £3.1 million ($3.9 million) from the Wellcome Trust.
US tech start-up teams up with Meat and Livestock Australia on significant cattle health pilot
HerdDogg and Meat and Livestock Australia (MLA) are collaborating to take part in the largest real-time cattle health pilot study ever conducted.
Zoetis: The lesson of Z to A in animal health
Animal Pharm's correspondent Dr Sandeep Juneja – who heads up the AnimalHealthIndia consultancy – looks at Zoetis as an example of an important lesson in attaining and maintaining leadership for animal health companies.
Heska to build greater presence in Australia, NZ
US veterinary diagnostics specialist Heska is aiming to add more local distribution partners in Australia and New Zealand.
Latest Articles
Analysis of Elanco's future
New Elanco starts to take shape as Q2 reveals underlying growth drivers
Elanco has pared down its non-core assets over the course of its strategic review and now has an underlying business that signals a more positive future.
Recent Tweets from Animal Pharm
Tweets by animalpharm
Commercial
Exchange rates, US de-stocking mask Virbac's healthier underlying Q2 performance
Virbac sales declined by 0.7% in the second quarter of the year – a performance obscured by currency exchange rates.
Latest From Commercial
Panion set for October FDA pre-submission date
Panion Animal Health has been assigned a pre-submission meeting with the US FDA for its gene therapy treatment for dogs with drug-resistant epilepsy.
Bayer management team benefits from internal promotions
The management team for Bayer Animal Health has seen five recent changes – all internal promotions.
Cargill opens sixth aqua innovation center in Asia
Cargill has opened an aquaculture innovation center in Indonesia to raise farming and feeding standards.
Sanderson Farms, consumer groups to face off over '100% Natural' claims
Parties will face off at the end of August in a federal court over Sanderson Farms' latest move to throw out a challenge by consumer groups for advertising its chicken products as '100% Natural'.
ImmuCell battling against dairy market slump, lack of inventory
US firm ImmuCell believes the impact of a soft dairy market on its business will subside over time.
US investment firm enters animal health by acquiring Stratford Pharmaceuticals
Eli Global has acquired 100% of companion animal dermatology specialist Stratford Pharmaceuticals from its shareholders.
Top Interviews & Analysis
Anizome: 'The microbiome is breaking down the barrier between nutrition and health'
Following the recent launch of animal microbiome discovery start-up Anizome, Animal Pharm editor Joseph Harvey spoke to the company's chief executive. Oliver Hardcastle explained why he thinks a greater understanding of the animal microbiome could be an industry gamechanger.
Products
Piedmont to provide Perrigo with pipeline of companion animal medications
Perrigo and Piedmont Animal Health will work together to develop and commercialize companion animal drugs.
Latest From Product
Biogénesis Bagó's FMD work shows vaccine development in China is a global game
Argentine company Biogénesis Bagó has been one of the most active international animal health businesses in China's veterinary vaccines market.
ImmuCell battling against dairy market slump, lack of inventory
US firm ImmuCell believes the impact of a soft dairy market on its business will subside over time.
ADM continues to increase animal nutrition expertise as Probiotics deal closes
US firm Archer Daniels Midland (ADM) has built on its growing status as an animal nutrition leader with its second acquisition in this area during 2018.
Piedmont, Norbrook gain generic approvals for pets and livestock
Piedmont Animal Health and Norbrook Laboratories are among several firms to have gained recent product approvals from the US FDA.
Amlan International adds ex-Novus head as new president
Amlan International has appointed Flemming Mahs as its new president, replacing retiring predecessor Ron Cravens.
BioZyme makes personnel changes to keep up with business growth
US livestock nutrition and animal microbiology firm BioZyme has made several changes to its staff in line with company growth.
Data Pharm
Animal Pharm M&A Table 2018
Featured here are the animal health mergers and acquisitions covered by Animal Pharm during 2017.
Ouro Fino turnaround reflected on stock market
Brazil's biggest animal health firm Ouro Fino Saúde Animal recently saw the first significant spike in its share price in the last eight months.
Sectors
Boehringer aims to help Latin America realize its potential through innovation
Fabio Paganini, the head of Boehringer Ingelheim's Latin America division, joined the firm just after its integration with Merial. At the recent Animal Health Innovation LatAm conference in São Paulo, Animal Pharm editor Joseph Harvey spoke to him about the firm's regional growth plans.
Latest From Sector
Biogénesis Bagó's FMD work shows vaccine development in China is a global game
Argentine company Biogénesis Bagó has been one of the most active international animal health businesses in China's veterinary vaccines market.
Sanderson Farms, consumer groups to face off over '100% Natural' claims
Parties will face off at the end of August in a federal court over Sanderson Farms' latest move to throw out a challenge by consumer groups for advertising its chicken products as '100% Natural'.
Piedmont, Norbrook gain generic approvals for pets and livestock
Piedmont Animal Health and Norbrook Laboratories are among several firms to have gained recent product approvals from the US FDA.
DSM in patent infringement case against Chinese firm
Royal DSM is pursuing a patent infringement lawsuit against a Chinese company regarding Biotin – a vitamin for both humans and animals.
Zoetis to take diagnostic tech and monoclonal antibodies to livestock sector
Zoetis sees a great opportunity in developing its diagnostic tools and monoclonal antibodies for food-producing animals.
CannPal to work with University of Melbourne to advance pipeline
Australian firm CannPal Animal Therapeutics has signed a collaboration with the University of Melbourne to broaden the company's pipeline.
Latest From Policy & Regulation
Equine vets regain access to flunixin as VMD relaxes restrictions
The UK's Veterinary Medicines Directorate (VMD) has relaxed recently implemented restrictions on the sale of flunixin by allowing the release of stock from manufacturers.
Southern Africa member states move to form AMR strategy
Southern Africa Development Community (SADC) member states will form a strategy to fight the spread of antimicrobial resistance (AMR) before the end of the year.
Biomin seeks zootechnical authorization for poultry in EU
Biomin has applied for a zootechnical status for its Digestarom DC feed additive in the EU.
AquaBounty predicts FDA to lift import alert on GE salmon this year
AquaBounty Technologies anticipates the US FDA will lift an import alert on its genetically-engineered (GE) salmon later this year – a move that would kick production into high gear.
UK urged to overturn flunixin suspension
The British Equine Veterinary Association (BEVA) has called for the Veterinary Medicines Directorate (VMD) to overturn its suspension of flunixin.
Contrasting reactions to new FDA antimicrobial plan
One advocacy group has questioned whether the new US FDA strategy on combating antimicrobial overuse will be specific enough to be effective.
Policy & Regulation
AnimalhealthEurope: Legislation is a positive step but more could have been done on innovation
AnimalhealthEurope has given a broadly positive response to new legislation that should ensure greater access to animal medicines and cut industry red tape.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.